News tagged with cholesterol drug

Ranbaxy recalls generic Lipitor doses

(AP)—Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once ...

Nov 23, 2012
popularity not rated yet | comments 0

Xeljanz approved for rheumatoid arthritis

(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.

Nov 07, 2012
popularity not rated yet | comments 0

Report: Cancer now leading cause of death in US hispanics

A new report from American Cancer Society researchers finds that despite declining death rates, cancer has surpassed heart disease as the leading cause of death among Hispanics in the U.S. In 2009, the most recent year for ...

Sep 17, 2012
popularity not rated yet | comments 0

HDL: Not so 'good' after all?

After years of having it drilled into their heads, most people now know that LDL (low-density lipoprotein) is the "bad" cholesterol package that increases the risk of cardiovascular disease, and HDL (high-density ...

Aug 28, 2012
popularity 5 / 5 (2) | comments 0

Potency of statins linked to muscle side effects

A study from the University of California, San Diego School of Medicine, published August 22 online by PLoS ONE, reports that muscle problems reported by patients taking statins were related to the strength or potency of the ...

Aug 22, 2012
popularity not rated yet | comments 1 | with audio podcast

Some drugs are going generic this year and next

Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations ...

Aug 03, 2012
popularity 5 / 5 (1) | comments 1

US regulators to decide on new weight loss drug

US regulators were expected to decide Tuesday whether to approve the second new anti-obesity drug in 13 years, Qnexa, which studies have shown may help some people lose up to 10 percent of their body weight.

Jul 17, 2012
popularity not rated yet | comments 0